483 Document: Cangene BioPharma, LLC dba Emergent BioSolutions, Feb 18, 2022

Name: FDA 483 Cangene BioPharma, Baltimore | February 2022
Brand: U.S. FDA
Price: 199 USD
Availability: InStock

On Feb 18, 2022, the FDA inspected Cangene BioPharma, LLC dba Emergent BioSolutions's Baltimore site. Explore the inspectional observations.